help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 8, 2003
Endocrinology, doi:10.1210/en.2002-0164
A more recent version of this article appeared on August 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/8/3586    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Estrada, M.
Right arrow Articles by Jaimovich, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Estrada, M.
Right arrow Articles by Jaimovich, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*CYPROTERONE ACETATE
*NANDROLONE
*TESTOSTERONE

Submitted on December 18, 2002
Accepted on May 1, 2003

Testosterone Stimulates Intracellular Calcium Release and Mitogen- Activated Protein Kinases Via a G-Protein Coupled Receptor in Skeletal Muscle Cells

Manuel Estrada1, Alejandra Espinosa1, Marioly Müller1, and Enrique Jaimovich1*

1 Centro de Estudios Moleculares de la Célula and Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, CASILLA 70005, SANTIAGO 6530499, CHILE

* To whom correspondence should be addressed. E-mail: ejaimovi{at}machi.med.uchile.cl.

Involvement of intracellular Ca2+ and extracelular signal-regulated kinases (ERK1/2) phosphorylation in the fast nongenomic effects of androgens in myotubes was investigated. Testosterone or nandrolone produced fast (less than 1 min) and transient increases in intracellular Ca2+, with an oscillatory pattern. Calcium signals were slightly reduced in Ca2+-free medium but lack of oscillations was evident. Signals were blocked by U-73122 and xestospongin B, inhibitors of inositol 1,4,5-trisphosphate (IP3) pathway. Furthermore, IP3 increased transiently 2- to 3-fold, 45 s after hormone addition. Cyproterone neither affected the fast Ca2+ signal, nor the increase in IP3. Calcium increases could also be induced by the impermeant testosterone conjugated to BSA (T-BSA) and the effect of testosterone was abolished in cells incubated with GDP{beta}S or pertussis toxin (PTX). Stimulation of myotubes either with testosterone, nandrolone or T-BSA increased immunodetectable phosphorylation of ERK1/2 within 5 min and this effect was not inhibited by cyproterone. Phosphorylation was blocked by use of BAPTA-AM, U-73122 and xestospongin B as well as by dominant negative Ras, MEK or the MEK inhibitor PD-98059. In addition, GDP{beta}S or PTX blocked ERK1/2 phosphorylation. These results are consistent with a fast effect of testosterone, involving a G protein linked receptor at the plasma membrane, IP3-mediated Ca2+ signal and Ras/MEK/ERK pathway in muscle cells.


Key words: nongenomic pathway • rogens • nandrolone • ERK phosphorylation • intracellular Ca2+ • G protein







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society